−1.24USD
−31.63 MUSD
About Belite Bio, Inc
Sector
CEO
Yue Hsin Lin
Headquarters
San Diego
Website
Employees (FY)
20
Founded
2018
ISIN
US07782B1044
FIGI
BBG016LJYT18
Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
